Researchers at the LKS Faculty of Medicine of the University of Hong Kong (HKUMed) have invented an oral formulation of ...

IN8bio (INAB) presented Phase 1 data on its allogeneic gamma-delta T cell therapy, INB-100, at the 2025 Transplantation & Cellular Therapy, ...

The five-year survival rate of children under 15 diagnosed with leukemia, which is a common form of cancer in childhood, stood at 88 percent. Children with a brain tumor showed a lower survival ...

A new international study has found that a simple tablet treatment could improve survival rates for people with chronic ...

More children are surviving cancer because of improved diagnostic methods and targeted treatment, figures from Dutch cancer ...

Leukemia is a leading cause of death among children in India, with over 30,000 cases diagnosed annually. Early diagnosis is ...

For patients with an average risk of relapse from acute lymphoblastic leukemia, survival rates rose to 97.5% with the new drug regimen vs. 90.2% for those without blinatumomab. For high-risk ...

Very sick patients who get a bone marrow transplant at Medical University of South Carolina survive at a much higher rate ...

IN8bio is accelerating patient enrollment in the INB-100 program and expects to complete enrollment of the expansion cohort in 2025. The company’s FDA discussions confirmed that relapse-free survival ...

Acalabrutinib–Venetoclax improves progression-free survival and reduces disease progression in untreated chronic lymphocytic ...